GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | - | - | ₹0.74 Cr | ₹1.70 Cr | ₹1.60 Cr |
What is the latest Contingent Liabilities ratio of GENNEX LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | - |
Mar2023 | - |
Mar2022 | ₹0.74 Cr |
Mar2021 | ₹1.70 Cr |
Mar2020 | ₹1.60 Cr |
How is Contingent Liabilities of GENNEX LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | 0 | |
Mar2023 | - | -100.00 | |
Mar2022 | ₹0.74 Cr | -56.70 | |
Mar2021 | ₹1.70 Cr | 6.11 | |
Mar2020 | ₹1.60 Cr | - |
Compare Contingent Liabilities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹348.6 Cr | 17.4% | 11.5% | -7.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | 17.4% |
11.5% |
-7.4% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses